Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs iShares International Treasury Bond ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while iShares International Treasury Bond ETF trades at $39.67 (market cap $1.31B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 23.7× iShares International Treasury Bond ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares International Treasury Bond ETF pays none. Which is the better fit depends on your goals.
| GEHC | IGOV | |
|---|---|---|
Market Cap | $31.07B | $1.31B |
Volume | 3,443,020 | 98,249 |
Sector | Health | Fixed Income |
52-Week High | $88.16 | $42.99 |
52-Week Low | $59.48 | $39.58 |
Enterprise Value | $39.53B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 92 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
IGOV trades at $39.67, showing modest daily gains of 0.23% amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, though oscillators suggest potential near-term momentum. Recent news highlights rising global bond yields creating headwinds for financial markets, while the company's key financial ratios remain undisclosed in current data.
The outlook remains cautious with technical indicators favoring bearish sentiment. Investment opportunities depend on improved fundamental metrics and market stabilization, while risks include persistent bond yield pressures and lack of clear profitability data. Stock investors should await clearer financial performance indicators before establishing positions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
